Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Omadacycline Tosilate Tablets

Approval Number

国药准字H20210049

Company再鼎医药（上海）有限公司

Registration Date

December 14, 2021

Drug Information

Generic Name

甲苯磺酸奥马环素片

Trade Name

纽再乐

Dosage Form

片剂

Strength

0.15g（按C29H40N4O7计）

Drug Type

化学药品

Registration Date

December 14, 2021

Company Information

Applicant Company

Company Name再鼎医药（上海）有限公司

Company Address

中国（上海）自由贸易试验区金科路4560号1号楼南楼4层

Manufacturing Company

Company Name江苏宣泰药业有限公司

Company Address

南通市海门区滨江街道珠海路163号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

甲苯磺酸奥马环素片 - NMPA 批准文号 | MedPath